Comparison between therapeotic effects of methylphenidate with rispredone in cristal dependent patients

Not Applicable

• Conditions: T43.6; methamphetamin dependency.

• Registration Number: IRCT201202159018N1
• Lead Sponsor: Tavana clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Methamphetamine dependence(More than 10 times the regular use of methamphetamine or 10 days); ;Positive Methamphetamine urien test ;
Age 18-65 ; note dependency to other opioid and opium ;
Exclusion : siezer;tardive dyskinesia or tic;
gravidity;past history of methyl phenidate craving;
past history of diabetes or MI;past history of allegy to rispredone;
past history of suicide;under treatment by anti psychotic drug or mood stabilizer or inhibitor CYP2D6 drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Craving. Timepoint: befor and during and after invetervention. Method of measurement: psycological exam.;Sleep condition improve. Timepoint: befor and during and after invetervention. Method of measurement: Beck questionnaire.;Psycotic reaction. Timepoint: befor and during and after invetervention. Method of measurement: Beck questionnaire and psycological exam.